Systemic lupus erythematosus and pregnancy;Lupus érythémateux systémique et grossesse

Presse Medicale

Volumn 37, Issue 11, 2008, Pages 1627-1635

  Le Guern, Véronique ^a   Pannier, Emmanuelle ^a   Goffinet, François ^a  

^a Université Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LABETALOL; METHOTREXATE; METHYLDOPA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

FEMALE FERTILITY; FETUS WASTAGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MULTIPLE CYCLE TREATMENT; NEPHRITIS; PREECLAMPSIA; PREGNANCY; PREMATURITY; PROGNOSIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATIENT CARE PLANNING; PATIENT CARE TEAM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; RISK FACTORS;

EID: 54949144259     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.09.001     Document Type: Short Survey

References (52)

1. Gordon P., Beedham T., Khamashta M., and D'Cruz D. Systemic lupus erythematosus in pregnancy. The obstetrician and gynaecologist 6 (2004) 80-87
2. Khamashta M.A. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 20 4 (2006) 685-694
3. Boumpas D.T., Austin III H.A., Vaughan E.M., Yarboro C.H., Klippel J.H., and Balow J.E. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119 5 (1993) 366-369
4. Le Thi Huong D., Wechsler B., and Piette J.C. Ovulation induction therapy and systemic lupus erythematosus. Ann Med Interne (Paris) 154 1 (2003) 45-50
5. Clowse M.E. Lupus activity in pregnancy. Rheum Dis Clin North Am 33 2 (2007) 237-252 v
6. Temprano K.K., Bandlamudi R., and Moore T.L. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35 2 (2005) 112-121
7. Cohen-Solal J.F., Jeganathan V., Grimaldi C.M., Peeva E., and Diamond B. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 305 (2006) 67-88
8. Grimaldi C.M. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol 18 5 (2006) 456-461
9. Doria A., Ghirardello A., Iaccarino L., Zampieri S., Punzi L., Tarricone E., et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum 51 6 (2004) 989-995
10. Beebe A.M., Cua D.J., and de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13 4-5 (2002) 403-412
11. Doria A., Cutolo M., Ghirardello A., Zampieri S., Vescovi F., Sulli A., et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 47 2 (2002) 202-209
12. Lockshin M.D., Reinitz E., Druzin M.L., Murrman M., and Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 77 5 (1984) 893-898
13. Lockshin M.D. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 32 6 (1989) 665-670
14. Meehan R.T., and Dorsey J.K. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14 2 (1987) 252-258
15. Urowitz M.B., Gladman D.D., Farewell V.T., Stewart J., and McDonald J. Lupus and pregnancy studies. Arthritis Rheum 36 10 (1993) 1392-1397
16. Tincani A., Faden D., Tarantini M., Lojacono A., Tanzi P., Gastaldi A., et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 10 5 (1992) 439-446
17. Carmona F., Font J., Cervera R., Munoz F., Cararach V., and Balasch J. Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 83 2 (1999) 137-142
18. Cortes-Hernandez J., Ordi-Ros J., Paredes F., Casellas M., Castillo F., and Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 41 6 (2002) 643-650
19. Petri M. Hopkins lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North Am 23 1 (1997) 1-13
20. Clowse M.E., Magder L.S., Witter F., and Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52 2 (2005) 514-521
21. Clowse M.E., Magder L., Witter F., and Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 11 (2006) 3640-3647
22. Costedoat-Chalumeau N., Amoura Z., Le Thi Huong D., Wechsler B., and Piette J.C. Pleading to maintain hydroxychloroquine throughout lupus pregnancies. Rev Med Interne 26 6 (2005) 467-469
23. Georgiou P.E., Politi E.N., Katsimbri P., Sakka V., and Drosos A.A. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 39 9 (2000) 1014-1019
24. Hayslett J.P., and Lynn R.I. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 18 2 (1980) 207-220
25. Clark C.A., Spitzer K.A., Nadler J.N., and Laskin C.A. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 30 10 (2003) 2127-2132
26. Lima F., Buchanan N.M., Khamashta M.A., Kerslake S., and Hughes G.R. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 25 3 (1995) 184-192
27. Bobrie G., Liote F., Houillier P., Grunfeld J.P., and Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 9 4 (1987) 339-343
28. Tandon A., Ibanez D., Gladman D.D., and Urowitz M.B. The effect of pregnancy on lupus nephritis. Arthritis Rheum 50 12 (2004) 3941-3946
29. Dhar J.P., Essenmacher L.M., Ager J.W., and Sokol R.J. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 193 4 (2005) 1444-1455
30. Yasmeen S., Wilkins E.E., Field N.T., Sheikh R.A., and Gilbert W.M. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10 2 (2001) 91-96
31. Magid M.S., Kaplan C., Sammaritano L.R., Peterson M., Druzin M.L., and Lockshin M.D. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 179 1 (1998) 226-234
32. Winer N., and Tsasaris V. Latest developments: management and treatment of preeclampsia. J Gynecol Obstet Biol Reprod (Paris) 37 1 (2008) 5-15
33. Chakravarty E.F., Colon I., Langen E.S., Nix D.A., El-Sayed Y.Y., Genovese M.C., et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192 6 (2005) 1897-1904
34. Chakravarty E.F., Nelson L., and Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54 3 (2006) 899-907
35. Moroni G., and Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol 16 2 (2003) 161-167
36. Tsatsaris V., Fournier T., and Winer N. Pathophysiology of preeclampsia. J Gynecol Obstet Biol Reprod (Paris) 37 1 (2008) 16-23
37. Qazi U., Lam C., Karumanchi S.A., and Petri M. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J Rheumatol 35 4 (2008) 631-634
38. Burkett G. Lupus nephropathy and pregnancy. Clin Obstet Gynecol 28 2 (1985) 310-323
39. Oviasu E., Hicks J., and Cameron J.S. The outcome of pregnancy in women with lupus nephritis. Lupus 1 1 (1991) 19-25
40. Huong D.L., Wechsler B., Vauthier-Brouzes D., Beaufils H., Lefebvre G., and Piette J.C. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 60 6 (2001) 599-604
41. Costedoat-Chalumeau N., Amoura Z., Duhaut P., Huong D.L., Sebbough D., Wechsler B., et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48 11 (2003) 3207-3211
42. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324 3 (1991) 150-154
43. de Boer N.K., Jarbandhan S.V., de Graaf P., Mulder C.J., van Elburg R.M., and van Bodegraven A.A. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 101 6 (2006) 1390-1392
44. Norgard B., Pedersen L., Fonager K., Rasmussen S.N., and Sorensen H.T. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 17 6 (2003) 827-834
45. Francella A., Dyan A., Bodian C., Rubin P., Chapman M., and Present D.H. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124 1 (2003) 9-17
46. Khamashta M.A., Ruiz-Irastorza G., and Hughes G.R. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 23 1 (1997) 15-30
47. Park-Wyllie L., Mazzotta P., Pastuszak A., Moretti M.E., Beique L., Hunnisett L., et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62 6 (2000) 385-392
48. Lockshin M.D., and Sammaritano L.R. Corticosteroids during pregnancy. Scand J Rheumatol Suppl 107 (1998) 136-138
49. Li D.K., Liu L., and Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. Bmj 327 7411 (2003) 368
50. Zandman-Goddard G., Levy Y., and Shoenfeld Y. Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 29 3 (2005) 219-228
51. Clowse M.E., Magder L., and Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 14 8 (2005) 593-597
52. Ostensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 3 (2006) 209